ATHENS, Ohio Faculty researchers from Ohio Universitys Heritage College of Osteopathic Medicine and Russ College of Engineering and Technology have received a $100,000 grant to investigate possible treatments for mitigating the severity of COVID-19.
Kelly McCall, Ph.D., and Douglas Goetz, Ph.D., will measure how effective a number of different chemical compounds are at preventing cytokine storms, a sometimes-fatal complication that can stem from COVID-19 infections, according to a news release.
The body responds to the presence of a pathogen by releasing a swarm of immune system proteins called cytokines to help fight off the virus or bacterium. If too many cytokines are released, a cytokine storm develops which can severely damage organs. This reaction is believed to be responsible for some of the deaths from COVID-19.
McCall is a professor in the Heritage College Department of Specialty Medicine and an investigator with its Diabetes Institute, and Goetz is a professor of chemical and biomolecular engineering in the Russ College.
Their award is a Fast Grant from Emergent Ventures, a fellowship and grant program at the Mercatus Center of George Mason University in Virginia. On April 7, the Center announced a grant program to provide funding for research on COVID-19. Reflecting the urgency of the worldwide search for ways to treat the pandemic, Goetz and McCall wrote the grant application in just three days, and it was approved within just a few days of its submission.
This is exciting and welcome news, Ohio University President M. Duane Nellis, Ph.D., said in the news release. The University has been eager to lend the expertise of our scientists to the urgent, cooperative global effort now underway to contain and treat COVID-19. Were grateful to Emergent Ventures Fast Grants program for recognizing the merits of Dr. McCall and Dr. Goetzs research proposal so quickly.
According to Goetz and McCall, inhibiting the action of GSK-3 enzymes, highly active catalysts believed to play a role in producing cytokine storms, might help prevent the storms. A handful of GSK-3 inhibitors have been or are now being used in clinical trials; the researchers will be testing the effectiveness of five of these compounds.
Im extremely grateful to Emergent Ventures for creating the opportunity for scientists from all over the world to work toward combating this devastating pandemic, Goetz said in the release. Im also thankful for my longtime colleague Dr. McCall and the talented Russ College students and Heritage College scientists who have put us in an excellent position to make a contribution to this endeavor.
McCall noted that the grant proposal stemmed from research she, Goetz and colleagues have been working on for years: studying how toll-like receptors, a class of proteins that play an important role in the immune system, are involved in producing cytokine storms. As part of this research, they have developed some compounds that are highly effective at inhibiting the action of an enzyme known as GSK-3.
We realized that these GSK-3 inhibitors may act to block the cytokine storm that can be induced by pathogens such as viruses and bacteria, McCall explained. Given the suspected role of cytokine storms in COVID-19 fatalities, Goetz and McCall realized that GSK-3 inhibitors might be used as a treatment.
They aim to test inhibitors already approved for safety, given how long it takes to get federal approval for a new drug for humans.
Our hope is, if those are useful for COVID-19, then hopefully it will save peoples lives in the short term, McCall said.
In the aftermath of the 2003 SARS epidemic (a less pervasive coronavirus disease), researchers utilized the spike protein from the SARS virus and found that the protein itself can trigger an innate immune response which is germane to cytokine storms. McCall and Goetz plan to take a similar approach, introducing the COVID-19 viruss spike protein to different types of cells, with and without the presence of an inhibitor, then comparing the levels of cytokines produced in each case. The spike protein projects from the surface of the virus and helps it attach itself to cells in a persons body, making it a key factor in the viruss ability to infect human cells.
Using the spike protein alone to trigger this response means the scientists will not need to have the virus present in their lab. Should they discover promising compounds, the team will partner with collaborators established through the Fast Grant network to test the compounds using SARS CoV-2 (the virus responsible for COVID-19) and patient samples.
As soon as the growing threat from COVID-19 became apparent, our college mobilized its resources quickly to do everything we could to help, from reinforcing our states health care workforce to donating protective equipment, said Ken Johnson, D.O., Heritage College executive dean and Ohio University chief medical affairs officer. This grant from Emergent Ventures allows Drs. McCall and Goetz to build on their existing research and, we hope, contribute to relieving the suffering caused by this worldwide pandemic.
Mei Wei, Ph.D., dean of the Russ College and Moss professor of engineering education, said, I congratulate Drs. McCall and Goetz for receiving the Emergent Ventures Fast Grant. I am very pleased to see that the collaborative work between Russ College faculty and faculty of the Heritage College can contribute to the better understanding of GSK-3 inhibitors for COVID-19, thereby helping mitigate the pandemic.
Continued here:
OHIO researchers win grant to study treatment for possible fatal complications of COVID-19 - Huntington Herald Dispatch
- Making Blood Stem Cells on a Microchip: Academic Minute - December 27th, 2022
- Novel detection of stem cell niche within the stroma of limbus in the rabbit during postnatal development | Scientific Reports - Nature.com - August 14th, 2022
- Why Nebraska's U.S. Airmen have filed a lawsuit refusing the COVID-19 vaccine - KETV Omaha - July 27th, 2022
- Hepatic stellate cells in liver development, regeneration, and cancer - July 11th, 2022
- Fasting triggers stem cell regeneration of damaged, old immune system ... - June 13th, 2022
- Columbus man to be one of first to receive transplant via new OhioHealth program - 10TV - April 19th, 2022
- Grayson authorizes more than $1 million for ongoing and new equine research in 2022 - EQUUS Magazine - March 25th, 2022
- Cancer stem cells in glioblastoma - January 20th, 2022
- First-responder cells after heart attack prompt ... - January 20th, 2022
- New clinical trials from University Hospitals Seidman Cancer Center to begin with human protein following successful on-site approach to producing and... - December 24th, 2021
- Riverside Biologics Health Review: At Home "Stem Cells ... - December 24th, 2021
- China-bound Graduate Focused on Global Goals - University of Mary Washington - December 10th, 2021
- Mustang Bio to Host Key Opinion Leader Webinar on MB-106, a Potential Treatment for B-Cell Non Hodgkin Lymphomas and Chronic Lymphocytic Leukemia -... - December 10th, 2021
- Fruit Cells, Space Bread, and Cultured Meat Cartridges: Deep Space Food Challenge Announces Phase 1 Winners - The Spoon - October 28th, 2021
- Fungi foray: Wild mushrooms are a key part of food chain - Farm and Dairy - August 5th, 2021
- AgeX Therapeutics Inc. (NYSE:AGE) stock surged in the premarket trading session; heres why - Market Globalist - May 13th, 2021
- University Hospitals treats first cancer patient in Ohio with "game changing" CAR T therapy - News 5 Cleveland - May 13th, 2021
- Weekly line: What the new coronavirus variants mean for vaccines, transmission, and more - The Daily Briefing - January 20th, 2021
- Forge Biologics Announces FDA Clearance of Investigational New Drug Application for Phase 1/2 Clinical Trial (RESKUE) of FBX-101 Gene Therapy for... - January 9th, 2021
- The Rise of Steve Sarkisian ... And the Decline of the Man Who Got Him Here - Sports Illustrated - January 9th, 2021
- Raleigh man delivers stem cells to patients around the world - WRAL.com - November 28th, 2020
- A real life Superman celebrates 5 years of survival from one of the deadliest cancers - Newswise - November 28th, 2020
- The Museum That Fell From the Sky | History - Air & Space Magazine - November 28th, 2020
- A Detroit Lions VP tries to avoid wasting her daughter from uncommon illness - The Shepherd of the Hills Gazette - November 28th, 2020
- US biotechnology company races to get its COVID-19 therapeutic approved for access, which has previously shown positive results in severely ill... - November 5th, 2020
- STEM CELLS - Regenerative Medicine Institute of Ohio - October 18th, 2020
- FDA Grants Orphan Drug Designation to Novel Bcl-2 inhibitor in CLL - Targeted Oncology - September 9th, 2020
- Breastfeeding 'even better than previously thought' - The Irish News - The Irish News - June 29th, 2020
- Regenerative Therapy Options for Horses With Osteoarthritis - TheHorse.com - June 12th, 2020
- Why Do Some People Get Sick All the Time, While Others Stay in Freakishly Good Health? - Discover Magazine - June 12th, 2020
- How safe are Ohio summer fun activities amid the coronavirus threat? The Wake Up for Friday, May 29, 2020 - cleveland.com - May 31st, 2020
- Kenneth Wallace Promoted to Full Professor at Clarkson University - Clarkson University News - May 31st, 2020
- ODDS AND ENDS: Melonheads and other offbeat offerings - Toronto Sun - May 31st, 2020
- Coronavirus Today: We're starting to reopen - Los Angeles Times - May 8th, 2020
- COMMENTARY || Pseudoscience and COVID-19we've had enough already - Folio - University of Alberta - May 3rd, 2020
- This Week in Green Tech: STEM Lessons, Solar Power and the Coronavirus, and More - ENGINEERING.com - May 3rd, 2020
- AskBio Announces First Patient Dosed in Phase 1 Trial Using AAV Gene Therapy for Congestive Heart Failure - BioSpace - February 7th, 2020
- Tune in Tonight: Oscar-nominated The Cave debuts on National Geographic - St. Augustine Record - January 25th, 2020
- Best Stem Cell Therapy Treatment in Cincinnati, Ohio ... - November 28th, 2019
- Time to Try Again: Gene-Based Therapy for Neurodegeneration - Alzforum - November 28th, 2019
- NIA Mourns the Loss of Dr. Huber Warner - National Institute on Aging - November 13th, 2019
- Research Roundup: Genomic Dark Matter Mutation and More - BioSpace - October 23rd, 2019
- Stem Cell Treatment Lima | Orthopaedic Institute of Ohio - September 10th, 2019
- Regenerative Therapy in Northeast Ohio | Ohio Therapy Centers - September 9th, 2019
- Stem cell therapy now available in central Ohio! - May 30th, 2019
- Stem Cell Therapy Clinic in Cleveland, Ohio - March 26th, 2019
- Massages & Treatments | Day Spa on Lake Erie in Ohio | The ... - March 10th, 2019
- *NEW* Regenerative Stem Cell Therapy | Ohio Therapy Centers - December 7th, 2018
- Stem Cell Therapy | Ohio Stem Cell - November 5th, 2018
- Ohio Stem Cell Treatment Center of Cleveland (Beachwood ... - November 3rd, 2018
- Conjoined twins - Wikipedia - September 20th, 2018
- Government website steers patients to unproven medical treatments - MyAJC - September 2nd, 2017
- Modern Health & Wellness of Lima institutes regenerative stem cell therapy - Lima Ohio - September 2nd, 2017
- Salk faces 'daunting' need for money despite big success with ... - The San Diego Union-Tribune - August 26th, 2017
- 'Nanotransfection' Turns Animal Skin into Blood Vessels and Brain ... - Medical Device and Diagnostics Industry - August 26th, 2017
- This Chip Uses Electricity to Reprogram Cells for Healing - Singularity Hub - August 25th, 2017
- This year's freshman class at Misericordia University is third largest in school history - The Dallas Post - August 25th, 2017
- Nanochip Could Heal Injuries or Regrow Organs with One Touch - NewsFactor Network - August 18th, 2017
- Wild new microchip tech could grow brain cells on your skin - CNET - August 8th, 2017
- Researchers explore possible alternative to knee replacement - Scope (blog) - August 5th, 2017
- Jackson Twp.'s Emmie Wanzer loves her new wheelchair swing provided by Wishes Can Happen Wanzer - Canton Repository - July 4th, 2017
- Scientists Discover That Fasting Triggers Stem Cell ... - November 23rd, 2016
- Stem-Cells | The Institute for Applied & Professional Ethics - November 18th, 2016
- Stem Cell Transplant Program - Cleveland, Ohio - October 17th, 2016
- Update: Ohio Stem Cell Study Recruiting People with MS ... - October 17th, 2016
- National Center For Regenerative Medicine - October 17th, 2016
- Stem-cell niche - Wikipedia, the free encyclopedia - October 19th, 2015
- Alex Potoczak of Ohio Praises Umbilical Stem Cell Research ... - July 2nd, 2015
- Dr. Foglietti | Ohio Stem Cell Treatment Center of Cleveland - April 27th, 2015
- Taubman Institute Receives $3 Million Wexner Gift to Support Emerging Physician-Researchers - April 3rd, 2015
- Morgan's Fund Launches Necrotizing Enterocolitis (NEC) Podcast Series: Premiere Features Dr. Gail Besner - March 24th, 2015
- Ohio Stem Cell Knee Arthritis Treatment-Regenexx - February 23rd, 2015
- We Were Promised Space Lasers: The State of the Union's Biggest Fibs - January 21st, 2015
- We Were Promised Space Lasers: State of the Union's Biggest Fibs - January 20th, 2015
- We Were Promised Space Lasers: The State of the Union's Big Fibs - January 17th, 2015
- 'Unprecedented': Drug May Help Heal Damaged Spines - December 4th, 2014
- New DNA discovery could lead to chromosome therapies in the future - November 19th, 2014
- Tiny Stomachs Grown in the Lab - October 31st, 2014
- Stem Cells Used to Grow Mini-Stomachs Seeking Treatments - October 30th, 2014
- Scientists build 'mini-stomachs' in lab - October 30th, 2014